356 related articles for article (PubMed ID: 22491401)
1. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.
Chen J; Joyal JS; Hatton CJ; Juan AM; Pei DT; Hurst CG; Xu D; Stahl A; Hellstrom A; Smith LE
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2968-77. PubMed ID: 22491401
[TBL] [Abstract][Full Text] [Related]
2. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
3. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.
Dal Monte M; Casini G; la Marca G; Isacchi B; Filippi L; Bagnoli P
Exp Eye Res; 2013 Jun; 111():27-35. PubMed ID: 23528535
[TBL] [Abstract][Full Text] [Related]
4. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina.
Liu XL; Zhou R; Pan QQ; Jia XL; Gao WN; Wu J; Lin J; Chen JF
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6625-32. PubMed ID: 20610844
[TBL] [Abstract][Full Text] [Related]
6. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.
Wang L; Shi P; Xu Z; Li J; Xie Y; Mitton K; Drenser K; Yan Q
Invest Ophthalmol Vis Sci; 2014 May; 55(7):4276-87. PubMed ID: 24867581
[TBL] [Abstract][Full Text] [Related]
8. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918
[TBL] [Abstract][Full Text] [Related]
9. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
Pan X; Lv Y
Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
[TBL] [Abstract][Full Text] [Related]
10. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
Budd SJ; Thompson H; Hartnett ME
Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
[TBL] [Abstract][Full Text] [Related]
11. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy.
Yun JH; Koh YJ; Jeong HS; Lee DH; Lee EH; Cho CH
Biochem Biophys Res Commun; 2018 Sep; 503(4):2792-2799. PubMed ID: 30100069
[TBL] [Abstract][Full Text] [Related]
12. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517
[TBL] [Abstract][Full Text] [Related]
14. Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.
Shaw LC; Li Calzi S; Li N; Moldovan L; Sengupta-Caballero N; Quigley JL; Ivan M; Jun B; Bazan NG; Boulton ME; Busik J; Neu J; Grant MB
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):858-869. PubMed ID: 29490339
[TBL] [Abstract][Full Text] [Related]
15. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.
Martini D; Monte MD; Ristori C; Cupisti E; Mei S; Fiorini P; Filippi L; Bagnoli P
J Neurochem; 2011 Dec; 119(6):1317-29. PubMed ID: 21988318
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of KH902 on retinal neovascularization.
Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
[TBL] [Abstract][Full Text] [Related]
20. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
Cheng G; He T; Xing Y
Eye (Lond); 2016 Jun; 30(6):877-87. PubMed ID: 26987588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
